Manninen V - Search Results

1

Effect of activated charcoal on hypercholesterolaemia.

Kuusisto P, Vapaatalo H, Manninen V, Huttunen JK, Neuvonen PJ. Kuusisto P, et al. Among authors: manninen v. Lancet. 1986 Aug 16;2(8503):366-7. doi: 10.1016/s0140-6736(86)90054-1. Lancet. 1986. PMID: 2874369

2

Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.

Neuvonen PJ, Kuusisto P, Vapaatalo H, Manninen V. Neuvonen PJ, et al. Among authors: manninen v. Eur J Clin Pharmacol. 1989;37(3):225-30. doi: 10.1007/BF00679774. Eur J Clin Pharmacol. 1989. PMID: 2612535 Clinical Trial.

3

The mechanism of the hypocholesterolaemic effect of activated charcoal.

Neuvonen PJ, Kuusisto P, Manninen V, Vapaatalo H, Miettinen TA. Neuvonen PJ, et al. Among authors: manninen v. Eur J Clin Invest. 1989 Jun;19(3):251-4. doi: 10.1111/j.1365-2362.1989.tb00226.x. Eur J Clin Invest. 1989. PMID: 2509211

4

HDL-cholesterol as a risk factor in coronary heart disease. An update of the Helsinki Heart Study.

Frick MH, Manninen V, Huttunen JK, Heinonen OP, Tenkanen L, Mänttäri M. Frick MH, et al. Among authors: manninen v. Drugs. 1990;40 Suppl 1:7-12. doi: 10.2165/00003495-199000401-00004. Drugs. 1990. PMID: 2289410 Clinical Trial.

5

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Frick MH, et al. Among authors: manninen v. N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001. N Engl J Med. 1987. PMID: 3313041 Clinical Trial.

6

High-density lipoprotein cholesterol elevation with gemfibrozil: effects of baseline level and modifying factors.

Mänttäri M, Tenkanen L, Mäenpää H, Manninen V, Huttunen JK. Mänttäri M, et al. Among authors: manninen v. Clin Pharmacol Ther. 1993 Oct;54(4):437-47. doi: 10.1038/clpt.1993.171. Clin Pharmacol Ther. 1993. PMID: 8222487 Clinical Trial.

7

Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels.

Mänttäri M, Koskinen P, Manninen V, Huttunen JK, Frick MH, Nikkilä EA. Mänttäri M, et al. Among authors: manninen v. Atherosclerosis. 1990 Feb;81(1):11-7. doi: 10.1016/0021-9150(90)90054-m. Atherosclerosis. 1990. PMID: 2407250 Clinical Trial.

8

Predictive value for coronary heart disease of baseline high-density and low-density lipoprotein cholesterol among Fredrickson type IIa subjects in the Helsinki Heart Study.

Manninen V, Koskinen P, Manttari M, Huttunen JK, Canter D, Frick HM. Manninen V, et al. Am J Cardiol. 1990 Sep 4;66(6):24A-27A. doi: 10.1016/0002-9149(90)90566-j. Am J Cardiol. 1990. PMID: 2392990

9

Lifestyle determinants of HDL2- and HDL3-cholesterol levels in a hypercholesterolemic male population.

Mänttäri M, Koskinen P, Manninen V, Tenkanen L, Huttunen JK. Mänttäri M, et al. Among authors: manninen v. Atherosclerosis. 1991 Mar;87(1):1-8. doi: 10.1016/0021-9150(91)90226-s. Atherosclerosis. 1991. PMID: 1872921

10

Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.

Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Mänttäri M, et al. Among authors: manninen v. Metabolism. 1991 Feb;40(2):217-21. doi: 10.1016/0026-0495(91)90179-z. Metabolism. 1991. PMID: 1988781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page